6 March 2017

Ceva honours rare livestock breeds during the French National Prize for Animal Agro biodiversity Awards ceremony >

The Fondation du Patrimoine and Ceva Santé Animale awarded the “Fondation du Patrimoine National Animal Agro-Biodiversity Prize” to 3 associations committed to preserving regional livestock breed, during the Paris International Agricultural Show.

20 February 2017

Ceva reinforces its position in China and swine through new joint-venture with EBVAC >

In the presence of the Chinese Prime Minister, Li Keqiang and French Prime Minister, Bernard Cazeneuve, Ceva Santé Animale (Ceva) and EBVAC today signed a joint-venture agreement to create a new business, Ceva EBVAC, focused on the swine sector.

8 February 2017

Ceva Santé Animale confirms its circle of virtuous growth in 2016 >

2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m as the Ceva Group continued to achieve double-digit growth, cementing its position as the 6th. largest animal health company.

30 January 2017

Ceva stresses the need for continued innovation to ensure effective disease control at IPPE 2017 >

Vectormune® ND, vaccine for Newcastle Disease (ND) Cevac IBird®, for Infectious Bronchitis (IB) prevention will continue to lead offerings for effective and easily administered disease control.

29 January 2017

Launch of the WVPA-Ceva joint Digital Library >

Launch of a digital library resource on poultry veterinary medicine

18 January 2017

Ceva completes deal to acquire portfolio of Merial swine & cattle vaccines and nonsteroidal anti-inflammatories from Boehringer Ingelheim >

19 January 2017: Ceva Santé Animale today completed the acquisition of a diversified portfolio of products, including swine and cattle vaccines and multi-species nonsteroidal anti-inflammatories from Boehringer Ingelheim following its acquisition of Merial Animal Health. All the products will be immediately available through local Ceva companies or its distributors, with no interruption of supply....

23 November 2016

Ceva acquires Hertape and Inova to enter Brazil’s top 5 animal health companies >

Move will increase the group global vaccine footprint with significant entry into the ruminant, Foot and Mouth disease market and a first entry into companion animal vaccines.

13 November 2016

Ceva Santé Animale given European Commission go ahead to acquire Merial assets from Boehringer Ingelheim >

The European Commission recently gave its approval for the transfer to Ceva Santé Animale of nine products developed and currently marketed by Merial.

2 November 2016

C.H.I.C.K Program receives the 1st independently audited quality recognition >

For the first time, an AH company services program receives internationally recognized quality approval from Bureau Veritas.

26 July 2016

Ceva sponsors IAHAIO Conference held in Paris >

Ceva reiterates its commitment to promoting the benefits of human-animal interaction (HAI)